We want others from other backgrounds whom we can turn to for long-term studies if we want to temporarily locate a vaccine, said Parliamentary Secretary of National Health Services Dr. Nausheen Hamid, reported APP.
Healthy participants are needed, read a notice from the hospital. Volunteers must be over 18 years of age, have no history of contracting COVID-19 and ideally not have an underlying disease; those with controlled underlying situations are also eligible.
The Pakistan trial is the main trial of the canSino vaccine being conducted in Argentina, Chile, Mexico, Saudi Arabia and Russia.
The vaccine, called Ad5, evolved through the Chinese company CanSino Biologics and the Institute of Biology of the Chinese Academy of Military Medical Sciences.
It is a modified form of adenovirus (cold virus) that will bring genetic clothing from the new coronavirus to cells. Once human cells are exposed, they will begin to produce a coronavirus protein and the body’s immune formula will recognize the protein and attack it.